Cutting Edge Information Blog2020-04-10T15:00:01-04:00

CUTTING EDGE INFORMATION BLOG

Contact Us
REQUEST A DEMO

January 30, 2020 - CEI is excited to launch our latest database of global fair market value rates. This database allows life science companies to determine appropriate compensation amounts for HCPs and other thought leaders. Thanks to our continued partnership with companies throughout the industry, we have refreshed our market data and published the most accurate global database to date. One of the biggest changes we are continuing to track is the rise in US FMV rates. Over the past three years US [...]

January 23, 2020 - Compliance and medical affairs teams who manage events must consider more than just the amount being paid to HCPs and other external advisors. While the hourly rate is a vital consideration, it is worth stepping back and assessing the engagement(s) as a whole. Groups should make sure that their focus is not so granular as to miss the forest for the trees. A recent whistleblower case revealed the willingness of courts to crack down on companies who are perceived [...]

January 2, 2020 - Whether it’s celebrating a career milestone or as part of a holiday tradition, professional relationships aren’t devoid of gift giving. And while pharma companies and HCPs can have close relationships, exchanging gifts—especially from companies to doctors—can be hazardous. In some cases, companies don’t engage in giving gifts because they come too close to violating federal bribery and anti-kickback regulations, but in other cases, state-level regulations have been put in place to explicitly curtail exchanges. One regulation worth mentioning is Minnesota’s [...]

December 5, 2019 - Industry group AdvaMed counts a wide range of medical device companies in its membership, and as such, its revised and restated code of ethics for interacting with US-based HCPs carries a fair amount of influence. Taking effect on January 1, 2020, the updated guidelines lay out the importance of, and benefits provided by, interactions between HCPs and medical device companies.  The document is divided into 13 sections that codify and provide guidance on most facets associated with engaging HCPs.  [...]

November 14, 2019 - Life science organizations account for a number of variables when deciding on an accurate FMV payment for contracted HCPs.  It’s a process that — at some point — involves confirming the title of an HCP in the context of a company’s engagement. A key factor in verifying a doctor’s title for FMV purposes stems from their personal career development.  Accomplished HCPs often hold multiple titles at the same time or move from one position to another in a short [...]

November 7, 2019 - Facilitating international thought leader (TL) events and engagements poses unique challenges for pharma companies. More specifically, having a high-level TL cross an international border for a compensated engagement is becoming more complex as a greater number of transfer-of-value regulations are being imposed on doctors and pharma companies.  A primary challenge associated with cross-border engagements is a TL’s country of origin. Most of the regulations mentioned above originate from single countries or, in some cases, federal states within countries. Unsurprisingly, [...]

October 17, 2019 - Thought leader (TL) compensation can include additional costs not immediately considered when coordinating a speaker engagement, consulting service or other activity. One of these additional costs involves transporting a contracted HCP from their home to the event location. To account for the variables that come with planning business travel, many pharma companies have developed TL travel policies. Company-wide TL travel policies help to ensure a consistent approach when handling events or other services. They typically outline the primary decision-maker [...]

October 10, 2019 - Since the inception of the Sunshine Act in 2010, life science companies operating in the US have had to disclose payments made to relevant health care providers (HCPs) and teaching hospitals in an online database. This legislation was largely focused on addressing the influence that pharma companies potentially had over HCPs’ and teaching hospitals’ prescribing habits. More recently, the Sunshine Act and physician payments database has expanded to include different types of nurses. This expansion stems directly from the [...]

Load More Posts